408 related articles for article (PubMed ID: 30459123)
1. Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers.
Nhola LF; Abdelmoneim SS; Villarraga HR; Kohli M; Grothey A; Bordun KA; Cheung M; Best R; Cheung D; Huang R; Barros-Gomes S; Pitz M; Singal PK; Jassal DS; Mulvagh SL
J Am Soc Echocardiogr; 2019 Feb; 32(2):267-276. PubMed ID: 30459123
[TBL] [Abstract][Full Text] [Related]
2. Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients.
Sonaglioni A; Albini A; Fossile E; Pessi MA; Nicolosi GL; Lombardo M; Anzà C; Ambrosio G
Cardiovasc Toxicol; 2020 Dec; 20(6):581-592. PubMed ID: 32519318
[TBL] [Abstract][Full Text] [Related]
3. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
Catino AB; Hubbard RA; Chirinos JA; Townsend R; Keefe S; Haas NB; Puzanov I; Fang JC; Agarwal N; Hyman D; Smith AM; Gordon M; Plappert T; Englefield V; Narayan V; Ewer S; ElAmm C; Lenihan D; Ky B
Circ Heart Fail; 2018 Mar; 11(3):e004408. PubMed ID: 29664405
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kaymakcalan MD; Xie W; Albiges L; North SA; Kollmannsberger CK; Smoragiewicz M; Kroeger N; Wells JC; Rha SY; Lee JL; McKay RR; Fay AP; De Velasco G; Heng DY; Choueiri TK
Cancer; 2016 Feb; 122(3):411-9. PubMed ID: 26540173
[TBL] [Abstract][Full Text] [Related]
6. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy.
Thavendiranathan P; Negishi T; Coté MA; Penicka M; Massey R; Cho GY; Hristova K; Vinereanu D; Popescu BA; Izumo M; Negishi K; Marwick TH;
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1109-1118. PubMed ID: 29778856
[TBL] [Abstract][Full Text] [Related]
7. Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: efficacy and toxicity.
Bellmunt J; Pons F; Foreshew A; Fay AP; Powles T; Porta C; Bracarda S; Lampron ME; Cerbone L; Sternberg CN; Hutson TE; Choueiri TK
Clin Genitourin Cancer; 2014 Aug; 12(4):262-9. PubMed ID: 24795159
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices.
Jonasch E; Signorovitch JE; Lin PL; Liu Z; Culver K; Pal SK; Scott JA; Vogelzang NJ
Curr Med Res Opin; 2014 Oct; 30(10):2041-50. PubMed ID: 24983741
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
10. Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients.
Iacovelli R; Ciccarese C; Fornarini G; Massari F; Bimbatti D; Mosillo C; Rebuzzi SE; Di Nunno V; Grassi M; Fantinel E; Ardizzoni A; Tortora G
Br J Clin Pharmacol; 2019 Jun; 85(6):1283-1289. PubMed ID: 30740760
[TBL] [Abstract][Full Text] [Related]
11. A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma.
Alimohamed N; Lee JL; Srinivas S; Bjarnason GA; Knox JJ; Mackenzie MJ; Wood L; Vaishampayan UN; Tan MH; Rha SY; Donskov F; Tantravahi S; Kollmannsberger C; North S; Rini BI; Choueiri TK; Heng DY
Clin Genitourin Cancer; 2014 Aug; 12(4):e127-31. PubMed ID: 24485801
[TBL] [Abstract][Full Text] [Related]
12. The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy.
Macfarlane R; Heng DY; Xie W; Knox JJ; McDermott DF; Rini BI; Kollmannsberger C; Choueiri TK
Cancer; 2012 Jan; 118(2):365-70. PubMed ID: 21717427
[TBL] [Abstract][Full Text] [Related]
13. The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients.
Hall PS; Harshman LC; Srinivas S; Witteles RM
JACC Heart Fail; 2013 Feb; 1(1):72-8. PubMed ID: 24621801
[TBL] [Abstract][Full Text] [Related]
14. Cardio-oncology: the role of advanced echocardiography in cancer patients.
Venneri L; Zoppellaro G; Khattar RS
Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular profile of contemporary treatments of renal cell carcinoma: A single-center prospective study.
Lee K; Lindenfeld L; Echevarria M; Hsu J; Wong FL; Narayan HK; Lau C; Cai L; Pal SK; Armenian SH; Rhee JW
Int J Cardiol; 2023 Jun; 380():40-46. PubMed ID: 36958393
[TBL] [Abstract][Full Text] [Related]
16. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
Golshayan AR; George S; Heng DY; Elson P; Wood LS; Mekhail TM; Garcia JA; Aydin H; Zhou M; Bukowski RM; Rini BI
J Clin Oncol; 2009 Jan; 27(2):235-41. PubMed ID: 19064974
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Rini BI; Michaelson MD; Rosenberg JE; Bukowski RM; Sosman JA; Stadler WM; Hutson TE; Margolin K; Harmon CS; DePrimo SE; Kim ST; Chen I; George DJ
J Clin Oncol; 2008 Aug; 26(22):3743-8. PubMed ID: 18669461
[TBL] [Abstract][Full Text] [Related]
18. Early detection of subclinical left ventricular dysfunction after breast cancer radiation therapy using speckle-tracking echocardiography: association between cardiac exposure and longitudinal strain reduction (BACCARAT study).
Walker V; Lairez O; Fondard O; Pathak A; Pinel B; Chevelle C; Franck D; Jimenez G; Camilleri J; Panh L; Broggio D; Derreumaux S; Bernier MO; Laurier D; Ferrières J; Jacob S
Radiat Oncol; 2019 Nov; 14(1):204. PubMed ID: 31727075
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials.
Sorich MJ; Kichenadasse G; Rowland A; Woodman RJ; Mangoni AA
Int J Cancer; 2016 May; 138(9):2293-9. PubMed ID: 26685869
[TBL] [Abstract][Full Text] [Related]
20. Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.
Narayan V; Keefe S; Haas N; Wang L; Puzanov I; Putt M; Catino A; Fang J; Agarwal N; Hyman D; Smith AM; Finkelman BS; Narayan HK; Ewer S; ElAmm C; Lenihan D; Ky B
Clin Cancer Res; 2017 Jul; 23(14):3601-3609. PubMed ID: 28196874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
